Javid Sadri Nahand

5.0k total citations · 2 hit papers
96 papers, 3.8k citations indexed

About

Javid Sadri Nahand is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Javid Sadri Nahand has authored 96 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 44 papers in Cancer Research and 18 papers in Infectious Diseases. Recurrent topics in Javid Sadri Nahand's work include MicroRNA in disease regulation (36 papers), Extracellular vesicles in disease (25 papers) and Cancer-related molecular mechanisms research (16 papers). Javid Sadri Nahand is often cited by papers focused on MicroRNA in disease regulation (36 papers), Extracellular vesicles in disease (25 papers) and Cancer-related molecular mechanisms research (16 papers). Javid Sadri Nahand collaborates with scholars based in Iran, South Africa and United States. Javid Sadri Nahand's co-authors include Hamed Mirzaei, Mohsen Moghoofei, Hamid Reza Mirzaei, Michael R. Hamblin, Arash Salmaninejad, Hossein Bannazadeh Baghi, Farah Bokharaei‐Salim, Fatemeh Momeni, Mohammad Reza Karimzadeh and Majid Rahmati and has published in prestigious journals such as Journal of Neurochemistry, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Javid Sadri Nahand

90 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast cancer diagnosis: Imaging techniques and biochemical markers

2017 348 citations Arash Salmaninejad, Javid Sadri Nahand et al. Journal of Cellular Physiology profile →
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

2023 88 citations Amirhossein Sheida, Mohammad Taghizadieh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javid Sadri Nahand Iran	38	2.3k	1.8k	485	478	459	96	3.8k
Li Zhou China	37	2.1k 0.9×	887 0.5×	807 1.7×	775 1.6×	558 1.2×	145	4.2k
Qianqian Zhu China	35	1.9k 0.8×	938 0.5×	458 0.9×	549 1.1×	437 1.0×	159	3.9k
Yufeng Yuan China	32	1.9k 0.8×	1.3k 0.7×	346 0.7×	315 0.7×	436 0.9×	114	3.3k
Xuebing Li China	29	1.8k 0.8×	819 0.5×	360 0.7×	259 0.5×	296 0.6×	145	3.3k
Ji‐Fu Wei China	35	3.2k 1.4×	1.5k 0.9×	217 0.4×	404 0.8×	451 1.0×	188	5.0k
Michael Zhuo Wang United States	20	2.4k 1.0×	1.1k 0.6×	481 1.0×	302 0.6×	235 0.5×	49	3.5k
César López‐Camarillo Mexico	34	2.0k 0.9×	1.1k 0.6×	258 0.5×	205 0.4×	496 1.1×	160	3.4k
Zhenggang Zhu China	32	2.2k 0.9×	1.1k 0.6×	343 0.7×	574 1.2×	854 1.9×	154	3.7k
Qun Lin China	37	3.4k 1.5×	1.8k 1.0×	663 1.4×	855 1.8×	1.1k 2.3×	127	6.5k
Kui Zhang China	37	2.4k 1.0×	740 0.4×	365 0.8×	794 1.7×	600 1.3×	188	4.5k

Countries citing papers authored by Javid Sadri Nahand

Since Specialization

Citations

This map shows the geographic impact of Javid Sadri Nahand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javid Sadri Nahand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javid Sadri Nahand more than expected).

Fields of papers citing papers by Javid Sadri Nahand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javid Sadri Nahand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javid Sadri Nahand. The network helps show where Javid Sadri Nahand may publish in the future.

Co-authorship network of co-authors of Javid Sadri Nahand

This figure shows the co-authorship network connecting the top 25 collaborators of Javid Sadri Nahand. A scholar is included among the top collaborators of Javid Sadri Nahand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javid Sadri Nahand. Javid Sadri Nahand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nahand, Javid Sadri, et al.. (2026). CAR-engineered cell therapies: current understandings and future perspectives. Molecular Biomedicine. 7(1). 7–7.

Shahabi, Parviz, et al.. (2025). Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment. Cancer Cell International. 26(1). 11–11.

Kesheh, Mina Mobini, Mohammad Yousef Memar, Hossein Bannazadeh Baghi, et al.. (2024). MicroRNAs and human viral diseases: A focus on the role of microRNA-29. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167500–167500. 10 indexed citations

Baghi, Hossein Bannazadeh, et al.. (2024). War or peace: Viruses and metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189179–189179. 14 indexed citations

Taghizadieh, Mohammad, et al.. (2024). The tumor microenvironment's gambit: Exosomal pawns on the board of head and neck cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189189–189189. 14 indexed citations

Nahand, Javid Sadri, et al.. (2024). Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment. Cell Biology and Toxicology. 40(1). 61–61. 16 indexed citations

Nahand, Javid Sadri, et al.. (2024). The evaluation of the expression pattern of the LncRNAs (AP006621.9, RP3-323A16.1, and HOXC-AS3), and their target genes (MTOR, TNF-α and TRAF6) in PBMC of long-term non-progressors and HIV-1 infected naive individuals. Gene Reports. 36. 101971–101971. 2 indexed citations

Aghbash, Parisa Shiri, et al.. (2024). Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy. Gene. 932. 148904–148904. 6 indexed citations

Nahand, Javid Sadri, et al.. (2023). Evaluation of expression pattern of cellular miRNAs (let-7b, miR-29a, miR-126, miR-34a, miR-181a-5p) and IL-6, TNF-α, and TGF-β in patients with pseudoexfoliation syndrome. Pathology - Research and Practice. 249. 154721–154721. 12 indexed citations

10.

Khatami, Alireza, Mohammad Taghizadieh, Javid Sadri Nahand, et al.. (2023). Evaluation of MicroRNA Expression Pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU and Diabetic COVID-19 Patients. Intervirology. 66(1). 63–76. 12 indexed citations

11.

Doroudian, Mohammad, et al.. (2023). Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo. Advanced Therapeutics. 6(10). 13 indexed citations

12.

Yekani, Mina, Solmaz Maleki Dizaj, Hossein Sedaghat, et al.. (2023). Preparation, biocompatibility, and antimicrobial effects of gelatin nanofibers scaffolds containing vancomycin and curcumin. Journal of Drug Delivery Science and Technology. 90. 105029–105029. 10 indexed citations

13.

Mirzaei, Hamed, Neda Rahimian, Hamid Reza Mirzaei, Javid Sadri Nahand, & Michael R. Hamblin. (2022). Exosomes and MicroRNAs in Biomedical Science. 13 indexed citations

14.

Memar, Mohammad Yousef, Abolfazl Jafari-Sales, Ahad Bazmani, et al.. (2022). The Effect of Oncogene Proteins of Human Papillomaviruses on Apoptosis Pathways in Prostate Cancer. ONCOLOGIE. 24(2). 227–245. 15 indexed citations

15.

Aghbash, Parisa Shiri, Ali Shamekh, Taher Entezari‐Maleki, et al.. (2022). SARS-CoV-2: Receptor and Co-receptor Tropism Probability. Current Microbiology. 79(5). 133–133. 48 indexed citations

16.

Nahand, Javid Sadri, Mohammad Taghizadieh, Mohammad Saeid Ebrahimi, et al.. (2021). Oncogenic viruses and chemoresistance: What do we know?. Pharmacological Research. 170. 105730–105730. 33 indexed citations

17.

Mostafaei, Shayan, Babak Sayad, Mohammad Doroudian, et al.. (2021). The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis. Respiratory Research. 22(1). 53–53. 24 indexed citations

18.

Nahand, Javid Sadri, Mohsen Moghoofei, Arash Salmaninejad, et al.. (2019). Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review. International Journal of Cancer. 146(2). 305–320. 187 indexed citations

19.

Moghoofei, Mohsen, Shayan Mostafaei, Abolfazl Nesaei, et al.. (2018). Epstein–Barr virus and thyroid cancer: The role of viral expressed proteins. Journal of Cellular Physiology. 234(4). 3790–3799. 48 indexed citations

20.

Tavakolizadeh, Jahanshir, Kambiz Roshanaei, Arash Salmaninejad, et al.. (2017). MicroRNAs and exosomes in depression: Potential diagnostic biomarkers. Journal of Cellular Biochemistry. 119(5). 3783–3797. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact